Navigation Links
Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results
Date:1/14/2009

SUNNYVALE, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its second quarter fiscal year 2009, ending December 27, 2008, on Thursday, January 29, 2009 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PST / 5:00 p.m. EST and will be hosted by Euan S. Thomson, Ph.D., president and chief executive officer, and Derek Bertocci, senior vice president and chief financial officer.

The conference call dial-in numbers are 1-866-379-2019 (USA) or 1-706-634-1525 (International), Conference ID: 80572858 In addition, a dial-up replay of the conference call will be available beginning January 29, 2009 at 5:00 p.m. PST / 8:00 p.m. EST and ending on January 31, 2009. The replay telephone number is 1-800-642-1687 (USA) or 1-706-645-9291 (International), Conference ID: 80572858.

A live webcast of the call will also be available from the Investor Relations section of the corporate Web site at http://www.accuray.com. A webcast replay can be accessed on the corporate Web site beginning Thursday, January 29, 2009 at approximately 5:00 p.m. PST / 8:00 p.m. EST. The replay will remain available until Accuray announces its results for the third quarter of fiscal 2009, ending March 28, 2009.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 50,000 patients worldwide and currently more than 150 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit http://www.accuray.com.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Accuray Incorporateds CEO to Speak at 27th Annual JP Morgan Healthcare Conference
2. Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide
3. Accuray Postpones Release of First Quarter Fiscal 2009 Results
4. Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009
5. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
6. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
7. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
8. Accuray Incorporateds CEO to Speak at CitiGroup Healthcare Conference
9. Accuray Wins Innovations in Healthcare(SM) ABBY Award
10. Accuray to Present at Citi Investment Research Small & Mid-Cap Conference
11. Accuray Announces New Treatment Planning Service Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):